To find a doctor, call 800-667-5356 or click below:

Find a Doctor

Request an Appointment

left banner
right banner
Smaller Larger

About Our Partnership

Providing Comprehensive Diabetes Specialty Care

Beth Israel Deaconess Medical Center (BIDMC) Joslin Diabetes Center are expanding and improving the longstanding clinical collaboration between these two world-class institutions to provide unparalleled preeminent specialty care for people with diabetes.

Joslin Clinic brings to the joint venture expertise in caring for and educating people with diabetes and their families, as well as proven disease management techniques for identifying patients at risk for developing medical complications and preventing those complications. BIDMC offers an extensive pool of physician specialists who have expertise in treating the complications of diabetes (i.e. heart disease, kidney and pancreas dysfunction, obesity and high-risk pregnancy).

The two nonprofit institutions, which are both affiliated with Harvard Medical School are strengthening current diabetes treatment and education programs. Joslin and BIDMC are creating new clinical guidelines and interactive programs in a number of areas including diabetes and cardiovascular disease; eye care for those with diabetes; kidney and pancreas transplantation as well as clinical trials of islet cell transplantation; high-risk pregnancy; and obesity, a major risk factor for the development of type 2 diabetes.

BIDMC and Joslin continue their collaboration with existing programs in vascular surgery for diabetes complications; clinical endocrinology; nephrology; mental health; podiatry services; and patient education and training. New emphasis is placed on joint programs for training specialists in the area of diabetes and endocrinology.

Poorly managed diabetes is a leading cause of end-stage kidney disease, heart attacks, strokes, eye disease and blindness, and other devastating and costly complications. Research has clearly demonstrated that expert diabetes care that keeps blood glucose near normal can reduce the risks of developing complications, and can slow the rate at which complications progress.

Successful diabetes management relies heavily on the patient, physician and healthcare team working together to coordinate medication (insulin and other drugs that help the body produce and use insulin) with diet, exercise and regular blood glucose monitoring to achieve good diabetes control and a healthy lifestyle.

BIDMC and Joslin continue to develop systems that support more efficient and effective delivery of care, including: a joint inpatient hospital coverage program; a shared electronic clinical information system that streamline medical consults and improve access to treatment specialists ; joint protocol development; comprehensive risk assessment and personalized disease management programs based on Joslin's disease management guidelines; and ongoing physician, staff and patient education. Patients will receive the highest quality care for diabetes and its complications.

BIDMC/Joslin with its innovative diabetes disease management approach, provides an unprecedented resource for community-based physicians and their patients. Community-based physicians will remain the heart of the patient care process. They will refer their patients with diabetes to Joslin/BIDMC for assessments, second opinions, evaluations, treatment plans, etc. Physicians will receive updates regarding the care of their patients and patients will continue to receive regular care from their PCP or their community specialist.

BIDMC/Joslinis creating new collaborative clinical practice approaches designed to prevent and treat diabetes and complications from diabetes. Examples include:

  • A diabetes and cardiovascular disease program designed to leverage BIDMC's historic strength in cardiovascular care and to address the fact that 80% of patients with diabetes die from cardiovascular and cerebrovascular disease. Work on this program has already begun with BIDMC clinicians partnering with Joslin to develop a proprietary clinical protocol algorithm aimed at screening patients for heart disease. This extraordinary new screening tool will help identify patients with diabetes who are at risk for heart disease and expedite referral to cardiology care at BIDMC.
  • The most advanced eye care for those with diabetes at the Joslin Clinic's Beetham Eye Institute.
  • Increased focus on kidney and pancreas transplantation at BIDMC, as well as clinical trials of islet cell transplantation.
  • Programs focused on high-risk pregnancy (gestational and pre-gestational diabetes).
  • Programs aimed at obesity, a major risk factor for the development of type 2 diabetes.

Joslin Diabetes Center, the global leader in diabetes research, care and education, is uniquely qualified to lead the battle against diabetes in the 21 st century. Joslin Research is a team of over 300 people at the forefront of discovery aimed at preventing and curing diabetes. Joslin Clinic, affiliated with Beth Israel Deaconess Medical Center, the nationwide network of Joslin Affiliated Programs, and the hundreds of Joslin educational programs offered each year for clinicians, researchers and patients enable Joslin to develop, implement and share innovations that immeasurably improve the lives of people with diabetes. As a non-profit, Joslin relies upon the generosity of donations to support its programs. For more information on Joslin, call 1-800-JOSLIN-1 or visit the Joslin Diabetes Center.

Contact Information

Endocrinology, Diabetes and Metabolism
Department of Medicine
Beth Israel Deaconess Medical Center
Shapiro Building
330 Brookline Avenue
Boston, MA 02215
617-667-9344
617-667-7060